Tumour tissues at the endpoint were also evaluated for iRFP fluorescence ex vivo, and immuno-stained for common markers of serous cancers including pan-cytokeratin (pan-CK), programmed death-ligand 1 (PD-L1), p53 and Wilms tumour protein (WT1). The gene discussed is WT1; the disease is neoplasm.